K2 Principal Fund’s DA32 Life Science Tech Acquisition Corp DALS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
– Sell
-39,505
Closed -$405K – 310
2023
Q2
$405K Buy
+39,505
New +$403K 0.09% 126

K2 Principal Fund's DALS Position: Q3 2023 in Review

K2 Principal Fund sold out of DA32 Life Science Tech Acquisition Corp (DALS) in Q3 2023, closing a stake of 39,505 shares — an estimated $405K sold.

K2 Principal Fund first reported a position in DALS in Q2 2023 and held it in 1 quarter. The position peaked at $405K in Q2 2023. 0 funds tracked by Wall St. Rank hold DALS as of Q3 2023.

  • K2 Principal Fund reported no remaining DA32 Life Science Tech Acquisition Corp position as of Q3 2023 after selling out during the quarter.
  • K2 Principal Fund sold 39,505 DA32 Life Science Tech Acquisition Corp shares in Q3 2023, an estimated $405K.
  • K2 Principal Fund first reported a position in DA32 Life Science Tech Acquisition Corp in Q2 2023 and held it in 1 quarter.
  • K2 Principal Fund's DA32 Life Science Tech Acquisition Corp position peaked at $405K in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DA32 Life Science Tech Acquisition Corp as of Q3 2023.

Based on K2 Principal Fund's 13F filing for Q3 2023, filed 13 Nov 2023.